Tiny implant which battles skin cancer to begin human trials
Cancer Research UK says that the technique shows 'real potential'
An implant the size of a fingernail that instructs immune cells to home in on and kill cancer cells has been put forward for clinical trials, which scientists hope could revolutionise the treatment of skin cancer.
The novel technique, one of several ground-breaking cancer vaccines in development, could also represent a new direction for treatments of other forms of cancer.
Researchers at Harvard University first trialled the implant in mice four years ago, but have now perfected their technique and received approval for human trials. The implant combats melanoma – the most lethal form of skin cancer.
Half the mice that received two doses of the vaccine showed complete regression of their cancer tumours.
Cancer Research UK said that the technique showed “real potential” to one day add to the growing “arsenal against cancer”.
The implant works like other vaccines by aiding the immune system’s ability to recognise and attack cancer cells. Research in the field of cancer vaccines is still in its early stages, but many scientists believe the techniques carry the potential for many future treatments. After a glut of major breakthroughs in recent years, development of some novel treatments has stalled, but the Harvard device heralds a possible new direction.
“It is rare to get a new technology tested in the laboratory and moved into human clinical trials so quickly,” said Glenn Dranoff, professor of medicine at Harvard Medical School. “We’re beyond thrilled with the momentum, and excited about its potential”.
The Phase I study in humans, which will test if the device is safe for clinical use, is expected to be complete by 2015, so it could be many years before the technique becomes available to patients.
Dr Emma Smith, Cancer Research UK’s senior science communications officer, said: “This is an early stage clinical trial to find out if a skin cancer vaccine is safe for patients, but larger trials will need to be run before we know if it can treat the disease and is better than the treatment that’s currently used. Harnessing our body’s own immune system to attack cancer is showing real potential and these types of novel approaches could mean expanding our arsenal against cancer.”
- 1 Which country would be hardest to invade?
- 2 The man who filmed the Freddie Gray video has been arrested at gunpoint
- 4 Floyd Mayweather's mouthguard costs $25,000 - enough to fly to Las Vegas and back 18 times
- 5 Royal baby girl born: Duchess of Cambridge's second child will be a princess thanks to Queen
Which country would be hardest to invade?
Morgan Freeman on the riot-focused coverage of the Baltimore protests: 'F**k the media'
The Rothschild Libel: Why has it taken 200 years for an anti-Semitic slur that emerged from the Battle of Waterloo to be dismissed?
The man who filmed the Freddie Gray video has been arrested at gunpoint
Nepal earthquake: Many survivors receiving no help despite relief effort
Over 50,000 families shipped out of London boroughs in the past three years due to welfare cuts and soaring rents
EU asylum policy is 'a direct threat to our civilisation', says Nigel Farage
Indonesia executions live: 'Hysterical' families heard prisoners being shot dead by firing squad
General Election 2015: SNP and its activists 'openly racist' towards the English, Farage says
EU exit would hit UK economy much harder than neighbouring countries, study finds
General Election 2015: UK will be 'run for the wealthy and powerful' if Tories retain power, Labour warns
£28000 - £45000 per annum: Recruitment Genius: A Senior Digital Marketing Cons...
£16640 - £18500 per annum: Recruitment Genius: An Assistant Stores Keeper is r...
£16000 - £18500 per annum: Recruitment Genius: This is an excellent opportunit...
£17000 - £30000 per annum: Recruitment Genius: Developer required to join a bu...